Methylphenidate is a stimulant drug that doctors prescribe to treat attention deficit hyperactivity disorder (ADHD) and narcolepsy. Learn about how it works, its side effects, and typical dosages ...

Methylphenidate Extended-Release prescription and dosage information for physicians and health care professionals. Pharmacology, adverse reactions, warnings, and Methylphenidate Extended ...

The drugs modafinil and methylphenidate have been shown to significantly improve the performance of chess players, though there are also some negative effects. Business Insider Subscribe Newsletters ...

Methylphenidate Chewable prescription and dosage information for physicians and health care professionals. Pharmacology, adverse reactions, warnings, and Methylphenidate Chewableside effects.

Hundreds of thousands of Australians who use a certain type of ADHD medication will be forced to use amphetamine-based ...

The U.S. Food and Drug Administration is revising the labeling of all extended-release attention-deficit/hyperactivity ...

In a large head-to-head trial, the response rate for methylphenidate (56%) was superior to that of atomoxetine (45%) for children and teens with ADHD.

Methylphenidate appears to be the best first-line drug choice for attention- deficit/hyperactivity disorder (ADHD) in children and adolescents, new research shows.

Methylphenidate mainly affected activation in the frontal lobes during inhibitory control tasks. During selective attention tasks, a wider range of brain areas were affected.

Attention Deficit Hyperactivity disorder (ADHD) affects around 11% of school-aged children and are often prescribed the psychostimulant, methylphenidate (Ritalin). Many patients with ADHD also have ...

This has been methylphenidate versus placebo for treating fatigue in people with advanced cancer, randomized, double-blind, multicenter, placebo-controlled clinical trial. And again, this is a dual ...

Methylphenidate in the drinking water (0.08%) significantly increased activity in the mid-to-late night, and led to a delay in the onset of activity and sleep relative to the light–dark cycle.